Deutsche Bank
TBIO

Deutsche Bank’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Deutsche Bank’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-145,901
Closed -$4.02M – 4791
2021
Q2 		$4.02M Sell
145,901
-3,293
-2% -$64.7K ﹤0.01% 1673
2021
Q1 		$2.46M Buy
149,194
+29,814
+25% +$679K ﹤0.01% 2021
2020
Q4 		$2.2M Sell
119,380
-242,098
-67% -$4.33M ﹤0.01% 1891
2020
Q3 		$4.92M Buy
361,478
+332,932
+1,166% +$5.13M ﹤0.01% 1269
2020
Q2 		$511K Buy
28,546
+16,185
+131% +$244K ﹤0.01% 2627
2020
Q1 		$124K Sell
12,361
-206
-2% -$1.69K ﹤0.01% 3163
2019
Q4 		$101K Buy
12,567
+4,214
+50% +$38.9K ﹤0.01% 3575
2019
Q3 		$82K Sell
8,353
-12,503
-60% -$118K ﹤0.01% 3667
2019
Q2 		$262K Sell
20,856
-13,884
-40% -$146K ﹤0.01% 3675
2019
Q1 		$352K Buy
34,740
+26,217
+308% +$201K ﹤0.01% 3663
2018
Q4 		$63K Sell
8,523
-13,702
-62% -$100K ﹤0.01% 4390
2018
Q3 		$222K Buy
+22,225
New +$259K ﹤0.01% 4191

Deutsche Bank's TBIO Position: Q3 2021 in Review

Deutsche Bank sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 145,901 shares — an estimated $4.02M sold.

Deutsche Bank first reported a position in TBIO in Q3 2018 and held it in 12 quarters. The position peaked at $4.92M in Q3 2020. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Deutsche Bank reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Deutsche Bank sold 145,901 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $4.02M.
  • Deutsche Bank first reported a position in Translate Bio, Inc. Common Stock in Q3 2018 and held it in 12 quarters.
  • Deutsche Bank's Translate Bio, Inc. Common Stock position peaked at $4.92M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.